Azole Antifungal [EPC]

Azole Antifungal [EPC] was reported 157204 times

These side effects are most commonly reported by patients taking drugs of the Azole Antifungal [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 14692
1 OFF LABEL USE 10997
2 DRUG INTERACTION 8235
3 PYREXIA 7688
4 NAUSEA 7070
5 DIARRHOEA 6617
6 FATIGUE 6334
7 PNEUMONIA 6057
8 DEATH 5514
9 DYSPNOEA 5446
10 HEADACHE 5400
11 PAIN 5327
12 FEBRILE NEUTROPENIA 4978
13 RASH 4823
14 CONDITION AGGRAVATED 4551
15 VOMITING 4388
16 ACUTE KIDNEY INJURY 4190
17 PRODUCT USE IN UNAPPROVED INDICATION 3875
18 ANAEMIA 3823
19 ASTHENIA 3705
20 NEUTROPENIA 3633
21 SEPSIS 3619
22 THROMBOCYTOPENIA 3584
23 RENAL FAILURE 3373
24 DIZZINESS 3277
25 PRURITUS 3171
26 MALAISE 3063
27 CONSTIPATION 2876
28 COUGH 2868
29 ABDOMINAL PAIN 2788
30 WEIGHT DECREASED 2769
31 ARTHRALGIA 2751
32 ANXIETY 2719
33 INFECTION 2715
34 PLATELET COUNT DECREASED 2689
35 HYPOTENSION 2634
36 PANCYTOPENIA 2494
37 DECREASED APPETITE 2474
38 FALL 2415
39 RESPIRATORY FAILURE 2412
40 ERYTHEMA 2408
41 HYPERTENSION 2392
42 CHRONIC KIDNEY DISEASE 2386
43 SEPTIC SHOCK 2345
44 URINARY TRACT INFECTION 2324
45 BACK PAIN 2243
46 PRODUCT USE ISSUE 2217
47 PAIN IN EXTREMITY 2209
48 FUNGAL INFECTION 2182
49 DRUG HYPERSENSITIVITY 2081
50 WHITE BLOOD CELL COUNT DECREASED 2034
51 DISEASE PROGRESSION 1956
52 CONFUSIONAL STATE 1925
53 OEDEMA PERIPHERAL 1906
54 HYPERSENSITIVITY 1873
55 DEPRESSION 1828
56 INSOMNIA 1799
57 RENAL IMPAIRMENT 1788
58 DEHYDRATION 1730
59 HYPOKALAEMIA 1706
60 ASTHMA 1691
61 PRODUCT DOSE OMISSION ISSUE 1686
62 HAEMOGLOBIN DECREASED 1672
63 CHEST PAIN 1665
64 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1636
65 PLEURAL EFFUSION 1630
66 BRONCHOPULMONARY ASPERGILLOSIS 1624
67 BLOOD CREATININE INCREASED 1594
68 ALOPECIA 1585
69 TREMOR 1584
70 ABDOMINAL PAIN UPPER 1552
71 ALANINE AMINOTRANSFERASE INCREASED 1546
72 WEIGHT INCREASED 1518
73 SOMNOLENCE 1517
74 NEUROPATHY PERIPHERAL 1490
75 TREATMENT FAILURE 1471
76 PULMONARY EMBOLISM 1462
77 ELECTROCARDIOGRAM QT PROLONGED 1456
78 GENERAL PHYSICAL HEALTH DETERIORATION 1425
79 CANDIDA INFECTION 1423
80 ASPERGILLUS INFECTION 1413
81 SINUSITIS 1408
82 MUCOSAL INFLAMMATION 1401
83 DRUG LEVEL INCREASED 1387
84 ASPARTATE AMINOTRANSFERASE INCREASED 1379
85 MYALGIA 1377
86 DRUG INTOLERANCE 1359
87 TOXICITY TO VARIOUS AGENTS 1353
88 ATRIAL FIBRILLATION 1352
89 HEPATIC ENZYME INCREASED 1336
90 HALLUCINATION 1331
91 COVID-19 1306
92 PSORIASIS 1303
93 GAIT DISTURBANCE 1296
94 NEUTROPHIL COUNT DECREASED 1288
95 PERIPHERAL SWELLING 1278
96 HYPOXIA 1266
97 CHILLS 1261
98 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1258
99 MUSCLE SPASMS 1258
100 MUSCULAR WEAKNESS 1231
101 HYPONATRAEMIA 1223
102 DRUG RESISTANCE 1219
103 DYSPHAGIA 1219
104 HYPOAESTHESIA 1217
105 UPPER RESPIRATORY TRACT INFECTION 1179
106 LEUKOPENIA 1167
107 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1167
108 TACHYCARDIA 1166
109 FEELING ABNORMAL 1153
110 CARDIAC ARREST 1150
111 JOINT SWELLING 1144
112 RENAL FAILURE ACUTE 1140
113 SKIN EXFOLIATION 1127
114 INFUSION RELATED REACTION 1113
115 ACUTE MYELOID LEUKAEMIA 1111
116 PARAESTHESIA 1110
117 NASOPHARYNGITIS 1107
118 HEPATIC FUNCTION ABNORMAL 1106
119 CARDIAC FAILURE 1099
120 DEEP VEIN THROMBOSIS 1097
121 VISION BLURRED 1097
122 HYPERHIDROSIS 1087
123 GASTROOESOPHAGEAL REFLUX DISEASE 1063
124 DYSPEPSIA 1062
125 URTICARIA 1060
126 EMOTIONAL DISTRESS 1058
127 VISUAL IMPAIRMENT 1052
128 CYTOKINE RELEASE SYNDROME 1049
129 ABDOMINAL DISCOMFORT 1047
130 BLOOD PRESSURE INCREASED 1040
131 STOMATITIS 1035
132 ORAL CANDIDIASIS 1032
133 OVERDOSE 1028
134 CYTOMEGALOVIRUS INFECTION 1016
135 LOSS OF CONSCIOUSNESS 1010
136 CELLULITIS 992
137 STAPHYLOCOCCAL INFECTION 991
138 RASH ERYTHEMATOUS 980
139 HEPATOTOXICITY 976
140 HOSPITALISATION 963
141 GASTROINTESTINAL HAEMORRHAGE 962
142 ABDOMINAL DISTENSION 958
143 HAEMOPTYSIS 951
144 BLOOD BILIRUBIN INCREASED 948
145 HAEMORRHAGE 945
146 RHABDOMYOLYSIS 930
147 SYNCOPE 927
148 GRAFT VERSUS HOST DISEASE 920
149 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 899
150 DRY SKIN 894
151 DRUG-INDUCED LIVER INJURY 891
152 BRONCHITIS 890
153 EXPOSURE DURING PREGNANCY 888
154 OROPHARYNGEAL PAIN 888
155 GASTROINTESTINAL DISORDER 879
156 C-REACTIVE PROTEIN INCREASED 878
157 CHOLESTASIS 873
158 INFLUENZA 873
159 OEDEMA 871
160 LUNG DISORDER 868
161 WHEEZING 864
162 SWELLING FACE 863
163 MACULAR DEGENERATION 860
164 SEIZURE 860
165 EPISTAXIS 859
166 BLISTER 849
167 BLOOD ALKALINE PHOSPHATASE INCREASED 849
168 CHEST DISCOMFORT 849
169 HYPERKALAEMIA 840
170 LIVER DISORDER 836
171 CONTUSION 829
172 BLOOD GLUCOSE INCREASED 820
173 END STAGE RENAL DISEASE 810
174 PALPITATIONS 807
175 DIABETES MELLITUS 800
176 SWELLING 799
177 THROMBOSIS 798
178 MULTI-ORGAN FAILURE 797
179 CEREBROVASCULAR ACCIDENT 794
180 DELIRIUM 786
181 INJURY 780
182 CARDIAC FAILURE CONGESTIVE 779
183 PHOTOSENSITIVITY REACTION 773
184 TOXIC EPIDERMAL NECROLYSIS 773
185 NEUROTOXICITY 763
186 INTENTIONAL PRODUCT MISUSE 761
187 COLITIS 758
188 HEART RATE INCREASED 756
189 PRODUCTIVE COUGH 749
190 LIVER FUNCTION TEST ABNORMAL 747
191 MEMORY IMPAIRMENT 734
192 RHEUMATOID ARTHRITIS 724
193 FLUID RETENTION 721
194 HEPATIC FAILURE 720
195 INTENTIONAL PRODUCT USE ISSUE 720
196 DYSPHONIA 719
197 MUCORMYCOSIS 715
198 LOWER RESPIRATORY TRACT INFECTION 712
199 OXYGEN SATURATION DECREASED 710
200 HALLUCINATION, VISUAL 707
201 STEVENS-JOHNSON SYNDROME 705
202 ANHEDONIA 699
203 BONE MARROW FAILURE 695
204 MYOCARDIAL INFARCTION 694
205 ENCEPHALOPATHY 692
206 TRANSAMINASES INCREASED 689
207 MALIGNANT NEOPLASM PROGRESSION 682
208 PULMONARY OEDEMA 679
209 BALANCE DISORDER 675
210 RASH MACULO-PAPULAR 675
211 INCORRECT DOSE ADMINISTERED 674
212 INTERNATIONAL NORMALISED RATIO INCREASED 667
213 HERPES ZOSTER 662
214 DRY MOUTH 658
215 IMMUNODEFICIENCY 658
216 INJECTION SITE PAIN 658
217 AGITATION 654
218 PSEUDOMONAS INFECTION 653
219 MENTAL STATUS CHANGES 649
220 GAMMA-GLUTAMYLTRANSFERASE INCREASED 648
221 HAEMATOCHEZIA 648
222 HYPERGLYCAEMIA 648
223 VULVOVAGINAL BURNING SENSATION 648
224 BRADYCARDIA 647
225 MYELOSUPPRESSION 646
226 BACTERAEMIA 645
227 PNEUMONIA FUNGAL 643
228 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 640
229 ILLNESS 637
230 BACTERIAL INFECTION 636
231 PATHOGEN RESISTANCE 635
232 THERAPY NON-RESPONDER 634
233 OSTEOPOROSIS 632
234 MUSCULOSKELETAL STIFFNESS 628
235 SKIN LESION 622
236 ACUTE RESPIRATORY DISTRESS SYNDROME 621
237 ARTHRITIS 621
238 RECTAL HAEMORRHAGE 610
239 DISSEMINATED INTRAVASCULAR COAGULATION 605
240 RESPIRATORY DISTRESS 604
241 MIGRAINE 603
242 BURNING SENSATION 599
243 INTERSTITIAL LUNG DISEASE 594
244 ASCITES 591
245 CONVULSION 591
246 BLOOD LACTATE DEHYDROGENASE INCREASED 589
247 LETHARGY 587
248 BLOOD PRESSURE DECREASED 583
249 RENAL DISORDER 580
250 SLEEP DISORDER 577
251 DISEASE RECURRENCE 574
252 RENAL INJURY 570
253 METABOLIC ACIDOSIS 568
254 HAEMATURIA 565
255 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 560
256 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 557
257 BONE PAIN 556
258 PANCREATITIS 555
259 WHITE BLOOD CELL COUNT INCREASED 555
260 DEPRESSED LEVEL OF CONSCIOUSNESS 550
261 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 550
262 LYMPHADENOPATHY 549
263 RASH PRURITIC 545
264 AGRANULOCYTOSIS 540
265 OSTEOARTHRITIS 536
266 ACUTE RESPIRATORY FAILURE 534
267 CONTRAINDICATED PRODUCT ADMINISTERED 534
268 NO ADVERSE EVENT 534
269 SWOLLEN TONGUE 530
270 EYE PAIN 528
271 JAUNDICE 523
272 OBSTRUCTIVE AIRWAYS DISORDER 518
273 PNEUMONITIS 518
274 MATERNAL EXPOSURE DURING PREGNANCY 510
275 ADRENAL INSUFFICIENCY 509
276 HYPOTHYROIDISM 509
277 DYSURIA 508
278 ARRHYTHMIA 507
279 MOUTH ULCERATION 505
280 PLASMA CELL MYELOMA 505
281 HYPOGLYCAEMIA 501
282 DRUG DOSE OMISSION 497
283 PULMONARY FIBROSIS 497
284 ENTEROCOCCAL INFECTION 495
285 PULMONARY MASS 495
286 CLOSTRIDIUM DIFFICILE COLITIS 494
287 ADVERSE DRUG REACTION 493
288 HYPERBILIRUBINAEMIA 490
289 DYSPNOEA EXERTIONAL 489
290 BLOOD POTASSIUM DECREASED 488
291 ECZEMA 488
292 MOBILITY DECREASED 487
293 PRESCRIBED OVERDOSE 487
294 RHINORRHOEA 487
295 TORSADE DE POINTES 487
296 ANGIOEDEMA 484
297 TREATMENT NONCOMPLIANCE 483
298 CATARACT 482
299 NECK PAIN 482
300 INFLAMMATION 481
301 APLASTIC ANAEMIA 480
302 PERICARDIAL EFFUSION 478
303 DEVICE RELATED INFECTION 477
304 CEREBRAL HAEMORRHAGE 475
305 CHOLELITHIASIS 472
306 CYSTITIS 472
307 LYMPHOCYTE COUNT DECREASED 470
308 SKIN DISORDER 470
309 CARDIAC DISORDER 463
310 NEPHROPATHY TOXIC 463
311 HEPATIC CYTOLYSIS 461
312 STRESS 460
313 RED BLOOD CELL COUNT DECREASED 459
314 ADVERSE EVENT 454
315 CYTOPENIA 454
316 HYPOMAGNESAEMIA 451
317 UNEVALUABLE EVENT 451
318 ECONOMIC PROBLEM 445
319 LIVER INJURY 444
320 MENTAL DISORDER 444
321 TUMOUR LYSIS SYNDROME 444
322 HEPATITIS 443
323 SUICIDAL IDEATION 441
324 RESPIRATORY DISORDER 439
325 COMA 438
326 FOOD ALLERGY 437
327 DRUG LEVEL BELOW THERAPEUTIC 434
328 LUNG INFECTION 434
329 DYSGEUSIA 433
330 CARDIO-RESPIRATORY ARREST 431
331 INFLUENZA LIKE ILLNESS 431
332 ACUTE GRAFT VERSUS HOST DISEASE 430
333 BLOOD UREA INCREASED 429
334 VIRAL INFECTION 428
335 CLOSTRIDIUM DIFFICILE INFECTION 427
336 NEUTROPENIC SEPSIS 425
337 NERVOUS SYSTEM DISORDER 424
338 NASAL CONGESTION 423
339 NEPHROLITHIASIS 421
340 VAGINAL DISCHARGE 419
341 DISCOMFORT 418
342 SHOCK 418
343 COAGULOPATHY 417
344 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 417
345 AMNESIA 415
346 HAEMATOCRIT DECREASED 415
347 FOETAL EXPOSURE DURING PREGNANCY 414
348 NEPHROGENIC ANAEMIA 412
349 FLUSHING 410
350 MUSCULOSKELETAL PAIN 407
351 TUBULOINTERSTITIAL NEPHRITIS 407
352 LIVER FUNCTION TEST INCREASED 405
353 DRUG LEVEL DECREASED 403
354 LEUKOCYTOSIS 402
355 HEPATOCELLULAR INJURY 401
356 ATELECTASIS 400
357 COLITIS ULCERATIVE 400
358 CYTOMEGALOVIRUS INFECTION REACTIVATION 400
359 DRUG ERUPTION 399
360 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 399
361 PANCREATITIS ACUTE 398
362 FLATULENCE 397
363 ALTERED STATE OF CONSCIOUSNESS 396
364 LUNG INFILTRATION 396
365 LYMPHOPENIA 395
366 CYTOMEGALOVIRUS VIRAEMIA 394
367 DISORIENTATION 394
368 PULMONARY ALVEOLAR HAEMORRHAGE 394
369 SQUAMOUS CELL CARCINOMA OF SKIN 394
370 THERAPEUTIC RESPONSE DECREASED 394
371 SKIN DISCOLOURATION 393
372 RESPIRATORY TRACT INFECTION 388
373 SKIN ULCER 388
374 MYELODYSPLASTIC SYNDROME 387
375 PRODUCT QUALITY ISSUE 387
376 VAGINAL HAEMORRHAGE 386
377 VENOOCCLUSIVE LIVER DISEASE 386
378 CHRONIC SINUSITIS 385
379 FULL BLOOD COUNT ABNORMAL 385
380 SYSTEMIC CANDIDA 383
381 POLLAKIURIA 380
382 VERTIGO 379
383 HOT FLUSH 378
384 PNEUMOTHORAX 377
385 URINARY INCONTINENCE 377
386 HYPOPHAGIA 376
387 VENTRICULAR TACHYCARDIA 373
388 BLOOD CHOLESTEROL INCREASED 371
389 ABORTION SPONTANEOUS 370
390 SPEECH DISORDER 370
391 DRY EYE 368
392 FOETAL DEATH 368
393 FREQUENT BOWEL MOVEMENTS 367
394 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 367
395 THROMBOTIC MICROANGIOPATHY 367
396 SURGERY 366
397 COGNITIVE DISORDER 365
398 DERMATITIS 365
399 KLEBSIELLA INFECTION 365
400 ANAPHYLACTIC REACTION 364
401 ARTHROPATHY 364
402 VASCULITIS 364
403 ORAL PAIN 362
404 THERAPY INTERRUPTED 362
405 DERMATITIS ATOPIC 361
406 PNEUMONIA ASPIRATION 361
407 EOSINOPHILIA 359
408 ACTINIC KERATOSIS 353
409 DYSARTHRIA 353
410 HAEMATOMA 353
411 TRANSPLANT REJECTION 353
412 APHASIA 352
413 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 350
414 NEURALGIA 346
415 PARAESTHESIA ORAL 346
416 SYSTEMIC MYCOSIS 346
417 THERAPEUTIC RESPONSE UNEXPECTED 346
418 ACUTE MYELOID LEUKAEMIA RECURRENT 345
419 LIP SWELLING 345
420 BURSITIS 344
421 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 343
422 RASH MACULAR 339
423 HYPERLIPIDAEMIA 338
424 VULVOVAGINAL PRURITUS 335
425 OSTEOMYELITIS 334
426 CANDIDIASIS 333
427 PRODUCT DOSE OMISSION 333
428 URINARY RETENTION 333
429 VULVOVAGINAL SWELLING 333
430 ELECTROLYTE IMBALANCE 330
431 NEUROLOGICAL SYMPTOM 329
432 BLOOD CREATINE PHOSPHOKINASE INCREASED 328
433 BRONCHIECTASIS 325
434 TINNITUS 325
435 PROCEDURAL PAIN 323
436 NEOPLASM MALIGNANT 322
437 SLEEP APNOEA SYNDROME 322
438 FULL BLOOD COUNT DECREASED 321
439 ILL-DEFINED DISORDER 321
440 MENINGITIS CRYPTOCOCCAL 321
441 VULVOVAGINAL PAIN 321
442 CORONARY ARTERY DISEASE 320
443 OSTEOPENIA 320
444 TACHYPNOEA 319
445 CHRONIC GRAFT VERSUS HOST DISEASE 318
446 GASTRITIS 317
447 OCULAR HYPERAEMIA 317
448 BRAIN OEDEMA 313
449 BLOOD SODIUM DECREASED 310
450 DISTURBANCE IN ATTENTION 310
451 ASPIRATION 309
452 HYPERCALCAEMIA 309
453 ASPERGILLOSIS 308
454 PNEUMONIA BACTERIAL 308
455 BONE DENSITY DECREASED 307
456 CEREBRAL INFARCTION 306
457 EYE IRRITATION 306
458 HYPOALBUMINAEMIA 306
459 SQUAMOUS CELL CARCINOMA 306
460 HAEMORRHOIDS 305
461 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 304
462 RENAL TUBULAR NECROSIS 304
463 PULMONARY HAEMORRHAGE 302
464 SPUTUM DISCOLOURED 302
465 MEDICATION ERROR 300
466 STAPHYLOCOCCAL SEPSIS 300
467 FUNGAEMIA 299
468 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 299
469 SKIN INFECTION 299
470 FEMALE GENITAL TRACT FISTULA 298
471 HYPOCALCAEMIA 298
472 HYPOPHOSPHATAEMIA 298
473 ORTHOSTATIC HYPOTENSION 298
474 BODY TEMPERATURE INCREASED 297
475 DIVERTICULITIS 297
476 SINUS TACHYCARDIA 297
477 ILEUS 295
478 SKIN IRRITATION 295
479 EPILEPSY 294
480 LACTIC ACIDOSIS 293
481 NIGHT SWEATS 293
482 RALES 293
483 RESPIRATORY SYMPTOM 293
484 ABSCESS 292
485 GENERALISED OEDEMA 292
486 NEOPLASM PROGRESSION 292
487 CYSTITIS HAEMORRHAGIC 290
488 EPSTEIN-BARR VIRUS INFECTION 290
489 OSTEONECROSIS 289
490 UNRESPONSIVE TO STIMULI 289
491 ORAL HERPES 288
492 BONE DISORDER 287
493 INTESTINAL OBSTRUCTION 287
494 ACNE 285
495 TEMPERATURE REGULATION DISORDER 285
496 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 283
497 HAIR TEXTURE ABNORMAL 283
498 PSORIATIC ARTHROPATHY 283
499 CONJUNCTIVITIS 281
500 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 281
501 INJECTION SITE ERYTHEMA 281
502 LEUKAEMIA 281
503 PHOTOPHOBIA 280
504 VISUAL ACUITY REDUCED 280
505 DEPRESSED MOOD 278
506 FUSARIUM INFECTION 277
507 NODULE 277
508 ACUTE MYOCARDIAL INFARCTION 276
509 DYSKINESIA 276
510 FEELING HOT 276
511 FUNGAL SKIN INFECTION 276
512 HAEMATEMESIS 276
513 TRANSIENT ISCHAEMIC ATTACK 276
514 STAPHYLOCOCCAL BACTERAEMIA 275
515 MELAENA 274
516 OESOPHAGEAL CANDIDIASIS 274
517 UNDERDOSE 274
518 IMPAIRED HEALING 272
519 MALNUTRITION 272
520 GRAFT VERSUS HOST DISEASE IN SKIN 271
521 PULMONARY HYPERTENSION 269
522 TYPE 2 DIABETES MELLITUS 269
523 ESCHERICHIA INFECTION 268
524 EYE SWELLING 268
525 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 267
526 THROAT IRRITATION 267
527 BLINDNESS 266
528 RASH GENERALISED 265
529 HEPATIC STEATOSIS 264
530 PROCTITIS 263
531 RESTLESSNESS 263
532 CRYPTOCOCCOSIS 262
533 EAR INFECTION 262
534 HEPATOMEGALY 262
535 BASAL CELL CARCINOMA 261
536 COELIAC DISEASE 261
537 PNEUMOCYSTIS JIROVECII PNEUMONIA 261
538 SEROTONIN SYNDROME 261
539 CHROMATURIA 260
540 RADICULOPATHY 260
541 LOCALISED INFECTION 258
542 TOXIC SKIN ERUPTION 258
543 OESOPHAGITIS 257
544 HEMIPARESIS 256
545 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 256
546 BLOOD TEST ABNORMAL 254
547 DEAFNESS 254
548 MYOSITIS 249
549 ARTERIOSCLEROSIS 248
550 HEART RATE DECREASED 248
551 MYOPATHY 248
552 LABORATORY TEST ABNORMAL 247
553 SHOCK HAEMORRHAGIC 247
554 GALLBLADDER DISORDER 245
555 LUNG OPACITY 245
556 SCEDOSPORIUM INFECTION 245
557 SKIN BURNING SENSATION 245
558 BACTERIAL SEPSIS 244
559 CROHN^S DISEASE 244
560 PAIN IN JAW 244
561 DRUG LEVEL ABOVE THERAPEUTIC 243
562 VULVOVAGINAL DISCOMFORT 243
563 NERVOUSNESS 242
564 PETECHIAE 242
565 PERITONITIS 241
566 DRUG EXPOSURE DURING PREGNANCY 240
567 HYPOACUSIS 240
568 ACCIDENTAL EXPOSURE TO PRODUCT 239
569 BK VIRUS INFECTION 239
570 PERIOSTITIS 239
571 EAR PAIN 237
572 FLUID OVERLOAD 237
573 SINUS DISORDER 237
574 ARTERIOSCLEROSIS CORONARY ARTERY 236
575 DIPLOPIA 236
576 HYPERPARATHYROIDISM SECONDARY 236
577 UPPER GASTROINTESTINAL HAEMORRHAGE 236
578 RIB FRACTURE 235
579 ABNORMAL BEHAVIOUR 234
580 HYPERSOMNIA 233
581 SEASONAL ALLERGY 233
582 BLOOD POTASSIUM INCREASED 232
583 HAEMODYNAMIC INSTABILITY 232
584 CEREBRAL ASPERGILLOSIS 231
585 MITRAL VALVE INCOMPETENCE 231
586 ENCEPHALITIS 230
587 INTERVERTEBRAL DISC PROTRUSION 230
588 BRAIN ABSCESS 229
589 VENTRICULAR FIBRILLATION 229
590 CUSHING^S SYNDROME 228
591 PANIC ATTACK 228
592 SPLENOMEGALY 228
593 CARDIOMEGALY 227
594 EYE DISORDER 226
595 GASTROENTERITIS 226
596 AGGRESSION 225
597 TRICUSPID VALVE INCOMPETENCE 225
598 APPLICATION SITE PAIN 224
599 HIATUS HERNIA 224
600 OSTEONECROSIS OF JAW 224
601 PREMATURE BABY 224
602 SCHIZOAFFECTIVE DISORDER 224
603 DRUG TOXICITY 223
604 ENDOPHTHALMITIS 223
605 FOOT FRACTURE 223
606 HYPERTRANSAMINASAEMIA 223
607 EJECTION FRACTION DECREASED 222
608 LIMB INJURY 222
609 ABDOMINAL PAIN LOWER 221
610 ACUTE HEPATIC FAILURE 221
611 BLOOD ALBUMIN DECREASED 221
612 BLOOD CALCIUM INCREASED 221
613 HOSPICE CARE 221
614 HEAD INJURY 219
615 IMMUNOSUPPRESSION 219
616 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219
617 VAGINAL FLATULENCE 219
618 HERPES SIMPLEX 218
619 ILEUS PARALYTIC 218
620 BLOOD GLUCOSE DECREASED 217
621 LACRIMATION INCREASED 217
622 THERAPY CESSATION 217
623 CIRCULATORY COLLAPSE 216
624 PHARYNGITIS 216
625 TRANSFUSION 216
626 HYPOGAMMAGLOBULINAEMIA 215
627 GENERALISED TONIC-CLONIC SEIZURE 214
628 IRRITABILITY 214
629 RASH PAPULAR 212
630 VENTRICULAR EXTRASYSTOLES 211
631 CHOLECYSTITIS 210
632 COVID-19 PNEUMONIA 210
633 DYSSTASIA 210
634 FEEDING DISORDER 210
635 IMPAIRED GASTRIC EMPTYING 210
636 PRESYNCOPE 210
637 FACE OEDEMA 209
638 HIP FRACTURE 209
639 HYPERCHOLESTEROLAEMIA 208
640 NEURITIS 208
641 WOUND 208
642 HAEMORRHAGE INTRACRANIAL 207
643 SPINAL OSTEOARTHRITIS 207
644 LYMPHOMA 206
645 GASTRIC ULCER 205
646 HEPATITIS CHOLESTATIC 205
647 BLOOD PRESSURE SYSTOLIC INCREASED 204
648 CARDIOMYOPATHY 204
649 MYOCLONUS 204
650 FAECES DISCOLOURED 203
651 ANGINA PECTORIS 202
652 GOUT 201
653 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 201
654 CHOLECYSTITIS CHRONIC 200
655 ORAL DISORDER 200
656 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 200
657 SUPRAVENTRICULAR TACHYCARDIA 200
658 FIBROMYALGIA 199
659 OLIGURIA 199
660 PROTEINURIA 199
661 DERMATITIS BULLOUS 198
662 SYSTEMIC LUPUS ERYTHEMATOSUS 198
663 BLOOD MAGNESIUM DECREASED 197
664 CENTRAL NERVOUS SYSTEM LESION 196
665 CARDIOGENIC SHOCK 195
666 ERYTHEMA MULTIFORME 194
667 ROAD TRAFFIC ACCIDENT 193
668 TASTE DISORDER 193
669 BLOOD TRIGLYCERIDES INCREASED 192
670 DRUG DEPENDENCE 192
671 EYE PRURITUS 191
672 FORCED EXPIRATORY VOLUME DECREASED 191
673 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 191
674 MUSCULOSKELETAL CHEST PAIN 191
675 REBOUND ACID HYPERSECRETION 191
676 SCIATICA 191
677 ADENOVIRUS INFECTION 190
678 DEVICE ISSUE 190
679 FAILURE TO THRIVE 190
680 PALLOR 190
681 RESPIRATORY SYNCYTIAL VIRUS INFECTION 190
682 INTERVERTEBRAL DISC DEGENERATION 189
683 NOCARDIOSIS 189
684 SINUS BRADYCARDIA 189
685 THERAPEUTIC PRODUCT EFFECT DECREASED 189
686 INTENTIONAL DOSE OMISSION 188
687 PULMONARY CONGESTION 188
688 PULMONARY VASCULITIS 188
689 GLAUCOMA 187
690 GAIT INABILITY 186
691 HAEMODIALYSIS 186
692 IMPAIRED QUALITY OF LIFE 186
693 INJECTION SITE BRUISING 186
694 LIMB DISCOMFORT 186
695 DERMATITIS CONTACT 185
696 ECCHYMOSIS 185
697 OBESITY 185
698 PERIPHERAL SENSORY NEUROPATHY 185
699 BLOOD PRESSURE FLUCTUATION 184
700 DRUG EFFECT INCOMPLETE 184
701 JOINT INJURY 184
702 TOOTHACHE 184
703 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 183
704 EMPHYSEMA 183
705 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 183
706 MULTIPLE SCLEROSIS RELAPSE 183
707 SCAR 183
708 THERAPY PARTIAL RESPONDER 183
709 TOOTH DISORDER 183
710 ANURIA 182
711 DIALYSIS 182
712 INJECTION SITE PRURITUS 182
713 RHINOVIRUS INFECTION 182
714 PLEURITIC PAIN 181
715 NORMOCHROMIC NORMOCYTIC ANAEMIA 180
716 SUBDURAL HAEMATOMA 180
717 UROSEPSIS 180
718 INJECTION SITE REACTION 179
719 CACHEXIA 178
720 DECUBITUS ULCER 178
721 RETCHING 178
722 ULCER 178
723 MULTIPLE FRACTURES 177
724 TENDERNESS 177
725 TOOTH INFECTION 177
726 VITAMIN D DEFICIENCY 176
727 CARDIOTOXICITY 175
728 GASTRIC DISORDER 175
729 PAIN OF SKIN 175
730 POST PROCEDURAL COMPLICATION 175
731 RESPIRATORY ARREST 175
732 SECRETION DISCHARGE 175
733 TOOTH ABSCESS 175
734 NEPHROPATHY 174
735 ENTEROCOLITIS 173
736 HALLUCINATION, AUDITORY 173
737 MOVEMENT DISORDER 173
738 THROAT TIGHTNESS 172
739 VAGINAL INFECTION 172
740 ABASIA 171
741 ACUTE LYMPHOCYTIC LEUKAEMIA 171
742 DRUG EFFECT DECREASED 171
743 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 171
744 HEART RATE IRREGULAR 171
745 JOINT STIFFNESS 171
746 BLOOD CALCIUM DECREASED 170
747 HAEMATOTOXICITY 170
748 IRON DEFICIENCY ANAEMIA 170
749 VENOOCCLUSIVE DISEASE 170
750 BLOOD COUNT ABNORMAL 169
751 PROTHROMBIN TIME PROLONGED 169
752 SINUS CONGESTION 169
753 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 168
754 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 168
755 CYTOMEGALOVIRUS TEST POSITIVE 168
756 HAIR COLOUR CHANGES 168
757 PSYCHOTIC DISORDER 168
758 ACIDOSIS 167
759 BRAIN FOG 167
760 COCCIDIOIDOMYCOSIS 167
761 KIDNEY INFECTION 167
762 ONYCHOMYCOSIS 167
763 POOR QUALITY SLEEP 167
764 STATUS EPILEPTICUS 167
765 DIFFUSE LARGE B-CELL LYMPHOMA 166
766 PRODUCT PRESCRIBING ISSUE 166
767 PURPURA 166
768 SKIN LACERATION 165
769 ATAXIA 164
770 INJECTION SITE SWELLING 164
771 RENAL FAILURE CHRONIC 164
772 UVEITIS 164
773 AGEUSIA 163
774 HISTOPLASMOSIS 163
775 IRRITABLE BOWEL SYNDROME 163
776 PRODUCT DOSE OMISSION IN ERROR 163
777 DIVERTICULUM 162
778 DRUG ABUSE 162
779 POLYNEUROPATHY 162
780 SCAB 162
781 SERUM FERRITIN INCREASED 162
782 ATRIAL FLUTTER 161
783 BOWEN^S DISEASE 161
784 FEMUR FRACTURE 161
785 NIGHTMARE 161
786 ANOREXIA 160
787 FEELING COLD 160
788 STEM CELL TRANSPLANT 160
789 VASCULAR DEVICE INFECTION 160
790 EATING DISORDER 159
791 HAEMOLYTIC ANAEMIA 159
792 IMMUNE SYSTEM DISORDER 158
793 MENINGITIS 158
794 SKIN CANCER 158
795 CARDIOVASCULAR DISORDER 157
796 DIABETIC KETOACIDOSIS 157
797 FOLLICULITIS 156
798 ACCIDENTAL OVERDOSE 155
799 HYDRONEPHROSIS 155
800 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 155
801 CARDIAC FAILURE ACUTE 154
802 APPLICATION SITE ERYTHEMA 153
803 BLOOD URINE PRESENT 153
804 LEFT VENTRICULAR DYSFUNCTION 153
805 PELVIC PAIN 153
806 ESCHERICHIA SEPSIS 152
807 MYCOBACTERIUM AVIUM COMPLEX INFECTION 152
808 NECROSIS 152
809 STENOTROPHOMONAS INFECTION 152
810 SUBARACHNOID HAEMORRHAGE 152
811 HEPATIC CIRRHOSIS 151
812 LUNG CONSOLIDATION 151
813 SINUSITIS FUNGAL 151
814 THERAPEUTIC RESPONSE SHORTENED 151
815 IMMUNE RECONSTITUTION SYNDROME 150
816 MENTAL IMPAIRMENT 150
817 NO THERAPEUTIC RESPONSE 150
818 BLOOD PRESSURE ABNORMAL 149
819 INFUSION SITE PAIN 149
820 MUSCLE ATROPHY 149
821 ERECTILE DYSFUNCTION 148
822 ESCHERICHIA BACTERAEMIA 148
823 NAIL DISCOLOURATION 148
824 PHARYNGEAL OEDEMA 148
825 SMALL INTESTINAL OBSTRUCTION 148
826 URINE OUTPUT DECREASED 148
827 BREATH SOUNDS ABNORMAL 147
828 EMOTIONAL DISORDER 147
829 FEAR 147
830 ROTATOR CUFF SYNDROME 147
831 SKIN FISSURES 147
832 TOOTH LOSS 147
833 BLOOD CULTURE POSITIVE 146
834 INTRACRANIAL PRESSURE INCREASED 146
835 MICTURITION URGENCY 146
836 PULMONARY MUCORMYCOSIS 146
837 QUALITY OF LIFE DECREASED 146
838 BRONCHOSPASM 145
839 CHOLECYSTITIS ACUTE 145
840 INTESTINAL PERFORATION 145
841 NEUTROPHIL COUNT INCREASED 145
842 ODYNOPHAGIA 145
843 PAPULE 145
844 VULVOVAGINAL MYCOTIC INFECTION 145
845 ANKLE FRACTURE 144
846 MYCOTIC ALLERGY 144
847 ORGANISING PNEUMONIA 144
848 SPINAL FRACTURE 144
849 CYANOSIS 143
850 DIABETES MELLITUS INADEQUATE CONTROL 143
851 EXPIRED PRODUCT ADMINISTERED 143
852 POTENTIATING DRUG INTERACTION 143
853 PRODUCT ADMINISTRATION INTERRUPTED 143
854 SKIN HYPERPIGMENTATION 143
855 TENDONITIS 143
856 GASTROENTERITIS VIRAL 142
857 NAIL DISORDER 142
858 CHEILITIS 141
859 MASS 141
860 MUSCLE TWITCHING 141
861 LABELLED DRUG-DRUG INTERACTION ISSUE 140
862 LIPASE INCREASED 140
863 MUSCULOSKELETAL DISCOMFORT 140
864 DENTAL CARIES 139
865 DERMATITIS EXFOLIATIVE 139
866 DISORGANISED SPEECH 139
867 FLANK PAIN 139
868 GINGIVAL BLEEDING 139
869 HICCUPS 139
870 MULTIPLE-DRUG RESISTANCE 139
871 PRURITUS GENERALISED 139
872 ISCHAEMIC STROKE 138
873 KIDNEY TRANSPLANT REJECTION 138
874 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 137
875 ENTEROCOCCAL BACTERAEMIA 137
876 LEUKAEMIA RECURRENT 137
877 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 137
878 BLOOD URIC ACID INCREASED 136
879 GLOSSODYNIA 136
880 WOUND INFECTION 136
881 CARDIAC MURMUR 135
882 LARGE INTESTINE PERFORATION 135
883 MITE ALLERGY 135
884 PLATELET COUNT INCREASED 135
885 SKIN REACTION 135
886 CARPAL TUNNEL SYNDROME 134
887 CRYING 134
888 CUSHINGOID 134
889 DIASTOLIC DYSFUNCTION 134
890 DISSEMINATED MUCORMYCOSIS 134
891 HAEMOLYSIS 134
892 HEPATITIS ACUTE 134
893 NEUTROPENIC COLITIS 134
894 ORAL DISCOMFORT 134
895 SPINAL COMPRESSION FRACTURE 134
896 APLASIA 133
897 DEMENTIA 133
898 INSURANCE ISSUE 133
899 LIVER ABSCESS 133
900 SKIN NECROSIS 133
901 SUBCUTANEOUS ABSCESS 133
902 DERMATITIS ALLERGIC 132
903 RESPIRATORY DEPRESSION 132
904 SKIN PLAQUE 132
905 TOTAL LUNG CAPACITY DECREASED 132
906 ACTIVITIES OF DAILY LIVING IMPAIRED 131
907 CONJUNCTIVITIS ALLERGIC 131
908 HYPERNATRAEMIA 131
909 HYPERTRIGLYCERIDAEMIA 131
910 PRODUCT PRESCRIBING ERROR 131
911 MOOD SWINGS 130
912 RESTLESS LEGS SYNDROME 130
913 SEBORRHOEIC DERMATITIS 130
914 SKIN HAEMORRHAGE 130
915 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 129
916 ACUTE PULMONARY OEDEMA 129
917 LOCAL SWELLING 129
918 PSEUDOMONAL SEPSIS 129
919 UPPER LIMB FRACTURE 129
920 BENIGN PROSTATIC HYPERPLASIA 128
921 ENTERITIS 128
922 PROCTALGIA 128
923 RED BLOOD CELL SEDIMENTATION RATE INCREASED 128
924 SEDATION 128
925 SENSORY DISTURBANCE 128
926 STREPTOCOCCAL INFECTION 128
927 TROPONIN INCREASED 128
928 INJECTION SITE HAEMORRHAGE 127
929 LUNG NEOPLASM MALIGNANT 127
930 NOCTURIA 127
931 RENAL CYST 127
932 CEREBRAL TOXOPLASMOSIS 126
933 SUICIDE ATTEMPT 126
934 DECREASED IMMUNE RESPONSIVENESS 125
935 DRUG WITHDRAWAL SYNDROME 125
936 DUST ALLERGY 125
937 EYE INFECTION 125
938 HEPATIC ENCEPHALOPATHY 125
939 HYPERURICAEMIA 125
940 ZYGOMYCOSIS 125
941 MALABSORPTION 124
942 MOOD ALTERED 124
943 MULTIPLE ALLERGIES 124
944 ORAL FUNGAL INFECTION 124
945 PNEUMONIA CYTOMEGALOVIRAL 124
946 TARDIVE DYSKINESIA 124
947 APPLICATION SITE PRURITUS 123
948 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 123
949 FEBRILE BONE MARROW APLASIA 123
950 HYPOAESTHESIA ORAL 123
951 MIXED LIVER INJURY 123
952 THIRST 123
953 ACINETOBACTER INFECTION 122
954 DISABILITY 122
955 GASTROINTESTINAL INFECTION 122
956 HERNIA 122
957 METASTASES TO BONE 122
958 NERVE INJURY 122
959 PSEUDOMEMBRANOUS COLITIS 122
960 ABNORMAL DREAMS 121
961 EMBOLISM 121
962 INFUSION SITE ERYTHEMA 121
963 LEUKOENCEPHALOPATHY 121
964 PRE-EXISTING CONDITION IMPROVED 121
965 TOTAL LUNG CAPACITY ABNORMAL 121
966 HYDROCEPHALUS 120
967 MULTIPLE MYELOMA 120
968 MULTIPLE SCLEROSIS 120
969 PNEUMONIA KLEBSIELLA 120
970 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 120
971 PYELONEPHRITIS 120
972 CYST 119
973 CYTOMEGALOVIRUS CHORIORETINITIS 119
974 DISSEMINATED ASPERGILLOSIS 119
975 ENDOCARDITIS 119
976 HERPES VIRUS INFECTION 119
977 PRESCRIBED UNDERDOSE 119
978 PSEUDOALDOSTERONISM 119
979 SNEEZING 119
980 VULVOVAGINAL CANDIDIASIS 119
981 BRAIN HERNIATION 118
982 DYSLIPIDAEMIA 118
983 HISTOPLASMOSIS DISSEMINATED 118
984 HYPERPHOSPHATAEMIA 118
985 LONG QT SYNDROME 118
986 PRODUCT AVAILABILITY ISSUE 118
987 FACIAL PAIN 117
988 JOINT RANGE OF MOTION DECREASED 117
989 SPIROMETRY ABNORMAL 117
990 ENTEROBACTER INFECTION 115
991 METASTASES TO LIVER 115
992 TUBERCULOSIS 115
993 DRUG ADMINISTRATION ERROR 114
994 GLOMERULAR FILTRATION RATE DECREASED 114
995 GRAND MAL CONVULSION 114
996 HALLUCINATIONS, MIXED 114
997 PERICARDITIS 114
998 RENAL TUBULAR DISORDER 114
999 SPUTUM INCREASED 114